Levodopa and subthalamic deep brain stimulation responses are not congruent
- PMID: 20824733
- DOI: 10.1002/mds.23294
Levodopa and subthalamic deep brain stimulation responses are not congruent
Abstract
There is a consensus that in Parkinson's disease, the extent of preoperative levodopa responsiveness predicts the efficacy of subthalamic nucleus deep brain stimulation (STN DBS). However, this may be the result of statistical methods and primary assumptions. We were able to reproduce previously published correlation results on our data (N = 49 patients). Yet, these same results were demonstrated even after random shuffling of our data. Notably, we did not observe a correlation between STN DBS efficacy and preoperative levodopa responsiveness when using their respective baselines and fractional scores of motor improvement. Furthermore, postoperative responses were not limited by preoperative scores, with tremor demonstrating the greatest discrepancy. We conclude that preoperative levodopa responsiveness does not predict or limit the outcome of STN DBS. These results imply different therapeutic mechanisms for levodopa and STN DBS and therefore question the validity of using substantial preoperative levodopa responsiveness as a selection criterion for STN DBS.
Similar articles
-
Subthalamic nucleus stimulation in Parkinson's disease patients intolerant to levodopa.Stereotact Funct Neurosurg. 2007;85(4):169-74. doi: 10.1159/000099076. Epub 2007 Jan 26. Stereotact Funct Neurosurg. 2007. PMID: 17259749 Clinical Trial.
-
Levodopa response in long-term bilateral subthalamic stimulation for Parkinson's disease.Mov Disord. 2007 May 15;22(7):990-7. doi: 10.1002/mds.21482. Mov Disord. 2007. PMID: 17443692 Clinical Trial.
-
Influence of subthalamic deep brain stimulation versus levodopa on motor perseverations in Parkinson's disease.Mov Disord. 2009 Jun 15;24(8):1206-10. doi: 10.1002/mds.22568. Mov Disord. 2009. PMID: 19412937 Clinical Trial.
-
Sedation with α2 Agonist Dexmedetomidine During Unilateral Subthalamic Nucleus Deep Brain Stimulation: A Preliminary Report.World Neurosurg. 2016 May;89:320-8. doi: 10.1016/j.wneu.2016.01.037. Epub 2016 Jan 22. World Neurosurg. 2016. PMID: 26805677 Review.
-
Deep-brain stimulation for Parkinson's disease.N Engl J Med. 2012 Oct 18;367(16):1529-38. doi: 10.1056/NEJMct1208070. N Engl J Med. 2012. PMID: 23075179 Review. No abstract available.
Cited by
-
Preoperative Levodopa Response and Deep Brain Stimulation Effects on Motor Outcomes in Parkinson's Disease: A Systematic Review.Mov Disord Clin Pract. 2021 Dec 9;9(2):140-155. doi: 10.1002/mdc3.13379. eCollection 2022 Feb. Mov Disord Clin Pract. 2021. PMID: 35146054 Free PMC article. Review.
-
Pallidal stimulation as treatment for camptocormia in Parkinson's disease.NPJ Parkinsons Dis. 2021 Jan 18;7(1):8. doi: 10.1038/s41531-020-00151-w. NPJ Parkinsons Dis. 2021. PMID: 33462205 Free PMC article.
-
Balance response to levodopa predicts balance improvement after bilateral subthalamic nucleus deep brain stimulation in Parkinson's disease.NPJ Parkinsons Dis. 2021 May 27;7(1):47. doi: 10.1038/s41531-021-00192-9. NPJ Parkinsons Dis. 2021. PMID: 34045471 Free PMC article.
-
Reaching to proprioceptively defined targets in Parkinson's disease: effects of deep brain stimulation therapy.Neuroscience. 2013 Aug 6;244:99-112. doi: 10.1016/j.neuroscience.2013.04.009. Epub 2013 Apr 13. Neuroscience. 2013. PMID: 23590906 Free PMC article. Clinical Trial.
-
Machine learning prediction of motor response after deep brain stimulation in Parkinson's disease-proof of principle in a retrospective cohort.PeerJ. 2020 Nov 18;8:e10317. doi: 10.7717/peerj.10317. eCollection 2020. PeerJ. 2020. PMID: 33240642 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical